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The UL33 gene of herpes simplex virus 1 (HSV-1) encodes a protein (pUL33) that is essential for the cleavage and packaging of
concatameric herpesvirus DNA into preformed capsids. Previous data have suggested that the UL33 protein interacts with the cleavage and
packaging proteins encoded by UL15 and UL28 that are known to associate with capsids. Examination of purified A capsids that lack DNA
and are derived from aborted packaging events, B capsids that lack DNA, and C capsids that contain DNA revealed an association of the
UL33 protein with all three capsid types. More UL33 protein was detected in A capsids than was present in B capsids. Capsid association was
susceptible to guanidine–HCl treatment and independent of the presence of UL15 or UL28. Capsid association of pUL33 was also
independent of UL6, which is believed to encode the portal into which DNA is inserted. These data suggest that pUL33 may act as part of the
capsid-associated molecular machinery that translocates cleaved genomic DNA into the capsid interior.
D 2004 Elsevier Inc. All rights reserved.Keywords: Cleavage; Packaging; UL33; Herpes simplex virus 1; CapsidsIntroduction
An essential step in the assembly of new herpesvirus
nucleocapsids is the cleavage of viral DNA concatamers into
individual genomes that are inserted into preformed capsids
(reviewed by Baines, 2001; Homa and Brown, 1997). This
step represents the merging of the DNA replication and
capsid assembly pathways and contains features reiterated
in a wide range of double-stranded DNA viruses.
The herpes simplex virus 1 (HSV-1) gene UL33 is ess-
ential for the cleavage and packaging of HSV DNA (Alko-
baisi et al., 1991) and encodes 19000 apparent Mr proteins
found in the cytoplasm and nuclear replication compart-
ments of infected cells (Reynolds et al., 2000). In addition to
pUL33, five other genes are similarly dispensable for capsid
formation but essential for HSV-1 DNA cleavage and
packaging: UL6, UL15, UL17, UL28, and UL32 (Addison
et al., 1984, 1990; Baines et al., 1997; Cunningham and
Davison, 1993; Lamberti and Weller, 1996, 1998; Patel et
al., 1996; Poon and Roizman, 1993; Salmon et al., 1998;0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.03.044
* Corresponding author. Fax: +1-607-253-3384.
E-mail address: jdb11@cornell.edu (J.D. Baines).Sherman and Bachenheimer, 1987; Taus et al., 1998;
Tengelsen et al., 1993; Weller et al., 1987; Yu et al.,
1997). In the absence of any of these six proteins, the viral
DNA is not cleaved and empty capsids accumulate in the
nuclei of infected cells.
Four types of capsids have been identified in cells
infected with HSV-1. The procapsid is believed to be the
progenitor of the other capsid types and has a spherical,
unstable, and relatively porous shell (Newcomb et al., 1996;
Trus et al., 1996). The shells of the other three capsid types,
A, B and C, are icosahedral, containing 20 faces and 12
vertices of fivefold symmetry (Booy et al., 1991; Wildy et
al., 1960; Zhou et al., 2000). Procapsids consist of an outer
shell surrounding uncleaved scaffold protein (preVP22a), A
capsids consist only of the outer capsid shell, B capsids
contain cleaved scaffold protein within the capsid shell, and
C capsids contain packaged DNA but lack most scaffold
proteins (Gibson and Roizman, 1972; Newcomb et al.,
1996). The cleavage of the scaffold protein in the procapsid
is believed to trigger a rearrangement of the outer shell such
that it forms the more stable icosahedron (Heymann et al.,
2003; Trus et al., 1996). Data largely support the hypothesis
that the entry of DNA is closely linked to this structural
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same reaction, A capsids are believed to arise from aborted
packaging events in which the scaffold is lost but DNA is
not retained, whereas B capsids are the consequence of
premature or asynchronous scaffold protein cleavage such
that the shell undergoes rearrangement before the scaffold is
degraded or expelled (Newcomb et al., 1996; Sherman and
Bachenheimer, 1987; Trus et al., 1996).
Two crucial components of the cleavage and packaging
reaction of dsDNA viruses are the portal protein and
terminase enzyme. The bacteriophage portal or connector
structure is found at one vertex of the capsid and is the site
of terminase and capsid interaction. The bacteriophage
portal structure is typically a ring-shaped dodecamer of
the portal protein, with the center of the ring forming the
channel through which the DNA is translocated into the
capsid (Bazinet and King, 1985; Lurz et al., 2001; Simpson
et al., 2000; Valpuesta et al., 2000; Yeo and Feiss, 1995).
The herpesvirus protein UL6 (pUL6) can assemble into ring-
shaped dodecamers and is found at only 1 of 12 vertices of
fivefold symmetry in herpesvirus B capsids (Newcomb et
al., 2001), suggesting that it forms the portal of the herpes-
virus capsid.
The terminase is a protein complex that binds and cleaves
concatameric DNA at the junction of two adjacent genomes.
Using the terminase complexes of bacteriophages as a
model, it is believed that the HSV terminase remains bound
to one free end of the cleaved DNA as it attaches to the
capsid. It then participates in DNA translocation until exactly
one genome is inserted into the capsid. The terminase then
cleaves the DNA a second time, releasing the genome from
the concatamer, and the terminase and remaining concata-
meric DNA disengage from the packaged capsid (Catalano,
2000). There is evidence that the HSV-1 UL15 and UL28
genes encode at least part of the terminase enzyme. The
proteins have been shown to interact in cells infected with
HSV-1 and when transiently expressed in the absence of
other HSV proteins (Abbotts et al., 2000; Beard et al., 2002;
Koslowski et al., 1997, 1999). In addition, the UL15 gene
encodes a region with similarities to a Walker A motif
present in a wide range of ATPases, including bacteriophage
terminases (Davison, 1992; Mitchell et al., 2002), and the
UL28 protein has been shown to bind sequences near the
genomic terminus that ensure the accuracy of the second
DNA cleavage event (Adelman et al., 2001; Hodge and
Stow, 2001). Both pUL15 and pUL28 can be detected in B
capsids but are less abundant in C capsids, suggesting that
they are lost once DNA is inserted (Salmon and Baines,
1998; Taus and Baines, 1998; Yu and Weller, 1998).
Recently, pUL33 has been shown to associate with both
UL15 and UL28, raising the possibility that pUL33 may
represent a third component of the terminase (Beard et al.,
2002). Preliminary results suggested that pUL33 was largely
absent from B capsids (Reynolds et al., 2000); however, the
discovery of the UL15–UL28–UL33 complex encouraged
further studies to determine whether pUL33 was a com-ponent of capsids, as might be expected of a terminase
subunit.Results
The UL33 protein associates with A, B, and C capsids in a
continuous sucrose gradient
Capsids were purified from HSV-1(F)-infected Vero
cells on a continuous 20–50% sucrose gradient as de-
scribed in Materials and methods. The gradient was then
fractionated and the proteins present in each fraction
electrophoretically separated on 8% and 15% denaturing
polyacrylamide gels. The proteins were transferred to
PVDF membranes and probed with polyclonal rabbit anti-
sera directed against the major capsid protein VP5 (Cohen
et al., 1980) or pUL33 (Reynolds et al., 2000). Bound
immunoglobulin was detected using the ECL+ system as
recommended by the manufacturer (Amersham Biotech). A
photograph of the immunoblot is shown in Fig. 1A. The
UL33 protein is present in the regions of the gradient
containing A, B, and C capsids, which are indicated by
the presence of the VP5 protein. Identical capsid purifica-
tion protocols were then carried out in the presence of
either DNase or RNase, the gradient fractionated and the
fractions examined for the presence of VP5 and pUL33 as
described above. Neither DNase nor RNase treatment of the
capsids affected the association of pUL33 with capsids
(data not shown).
It would be expected that if pUL33 were associated with
capsids, it would remain associated with highly purified
capsids. To test this possibility, the light scattering bands
containing the A, B, and C capsids from the first gradient
were collected, pooled, and separated on a second 20–50%
sucrose gradient, and the gradient was fractionated. The
proteins from each fraction were separated on 8% and 15%
polyacrylamide gels and probed with antisera directed
against VP5 or pUL33, respectively (Fig. 1B). Immunore-
activity specific for pUL33 was present in the region of the
gradient corresponding to the A and B capsid bands,
confirming the results obtained from the analysis of capsids
purified on a single gradient. Because relatively few C
capsids survived the additional purification steps, we could
not derive conclusions concerning the presence of pUL33 in
C capsids in this particular experiment.
As a further control experiment to ensure that pUL33
associated specifically with capsids and did not coinciden-
tally migrate in capsid-containing fractions, an identical
capsid purification protocol was carried out on Vero cells
infected with the mutant virus K23Z. The genome of K23Z
contains a LacZ expression construct replacing most of the
UL18 gene and is therefore unable to assemble capsids
(Desai et al., 1993). Examination of the gradient containing
lysates of K23Z-infected cells revealed no UL33 protein-
specific immunoreactivity (Fig. 1C), confirming that the
Fig. 1. Immunoblots of capsid associated proteins. Capsids from Vero cells infected with HSV-1(F) were purified through one (A) or two (B) continuous 14-ml
sucrose gradients. Fractions were collected starting at the top (fraction one) and electrophoretically separated on 8% (VP5, upper panels) or 15% (UL33, lower
panels) polyacrylamide gels. The proteins were transferred to PVDF membrane and probed with antisera directed against VP5 or pUL33. Bound substrate was
detected using the ECL+ detection system. The fractions containing A, B, or C capsids are indicated. C shows fractions of a second continuous sucrose gradient
containing a nuclear lysate from Vero cells infected with the K23Z mutant virus. Proteins in each fraction were separated on a 15% denaturing polyacrylamide
gel, transferred to PVDF, and probed with antisera directed against pUL33. The immunoblot was intentionally overdeveloped. Lane 1 contains mock-infected
cells, lane 2 lysate of K23Z infected cells, and lane 3 lysate of HSV-1(F)-infected cells. The arrow marks the position of pUL33. Lane 16 contains, as a positive
control, histagged recombinant pUL33 expressed in insect cells.
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dependent on the presence of capsids.
The UL33 protein is present in purified A capsids
To determine if the UL33 protein was present in A
capsids as well as B, nuclear lysates from twenty 175 cm2
flasks (approximately 4  108 cells) were purified as
described above on two successive sucrose gradients. The
A and B light scattering bands were collected separately
from the initial sucrose gradient, the capsids within them
pelleted, resuspended in minimal volume, and recentrifuged
on separate sucrose gradients. The light scattering bands
were then collected, the capsids within them pelleted, and
solubilized in SDS and h-mercaptoethanol. The A and B
capsid samples were then analyzed on immunoblots probed
with antibody specific for pUL33. Fig. 2A shows that
pUL33 was detected in both the A and B capsid samples.
Aliquots of the A and B capsid samples were also examined
on an 8% polyacrylamide gel stained with Coomassie blue.
The major scaffold protein VP22a, which is absent fromA capsids, was identified only in the B capsid sample,
confirming the fact that the A capsid preparation was
largely devoid of B capsids (Fig. 2B).
Quantification of the amount of pUL33 in A and B capsids
The relative amount of VP5 and pUL33 in highly purified
A and B capsids was compared in seven separate experi-
ments. On six occasions, as seen in Fig. 2A, there was
comparatively more pUL33 present in the A capsid sample,
even though, as the Coomassie-stained VP5 band in Fig. 2B
reveals, there were less A capsids than B capsids present. In
one of the seven experiments, there appeared to be more
pUL33 in B than A capsids. As it was not possible to purify
C capsids to the same standard as A and B capsids, they
were not included in the quantification analysis. Extensive
efforts were made to determine the absolute number of
copies of pUL33 in A and B capsids, as has been described
for pUL15 and pUL28 (Beard et al., 2004); however, the
substantial variability of the results prevented any conclu-
sions being drawn.
Fig. 3. Scanned digital image of coomassie stained gel (upper panel) or
immunoblot probed with antisera against the UL33 protein (lower
panel). B capsids were purified from Vero cells infected with HSV-1(F)
and treated with 0, 0.1, 0.25, 0.5 and 1 M guanidine hydrochloride as
indicated. The proteins were electrophoretically separated on an 8% or a
15% polyacrylamide gel. The 8% gel was stained with coomassie blue
to visualise the capsid proteins, while the 15% gel was transferred to
PVDF and pUL33 visualised by the ECL+ system.
Fig. 2. Scanned digital images of A and B capsid proteins electrophoret-
ically separated on 15% (A) and 8% (B) polyacrylamide gels. Proteins were
either transferred to PVDF, probed with antisera directed against pUL33,
and bound antibody visualized by the ECL+ system (A) or stained with
Coomassie blue (B). The positions of the capsid shell and scaffold proteins
are indicated on B.
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with B capsids
To investigate whether pUL33 was tightly or loosely
associated with capsids, B capsids were treated with
varying concentrations of GuHCl (Fig. 3A). The UL33
protein was found to be removed from the capsid when
exposed to increasing concentrations of GuHCl, sim-
ilar to the association of the capsid scaffold protein
VP22a (Fig. 3B).
The proteins encoded by genes UL6, UL15, and UL28 are
not necessary for pUL33 capsid association
Vero cells were infected with previously described
viruses individually lacking intact UL6, UL15, or UL28
genes (Baines et al., 1997; Patel and Maclean, 1995;
Tengelsen et al., 1993). The mutant B-like capsids from
the respective nuclear lysates were purified on two se-
quential sucrose gradients as described above. The second
gradient was fractionated, and the proteins present in each
fraction separated on a denaturing 8% or 15% polyacryl-
amide gel, transferred to nitrocellulose membranes, and
probed with antibodies directed against either VP5 or
pUL33. Immunoreactivity specific for the UL33 protein
was present only in fractions collected from the area of
the gradient corresponding to the B-like capsid bands;
these fractions also contained VP5 (Fig. 4). These data
indicate that in the absence of pUL6, pUL15, or pUL28,
the UL33 protein is still able to associate with B-like
capsids.The protein encoded by the UL28 gene associates with
capsids lacking pUL33
Previous work has reported the association of both
pUL6 and pUL15 with capsids lacking pUL33 (Patel et
al., 1996; Salmon et al., 1999). To determine if pUL28
associates with capsids lacking pUL33, Vero cells were
infected with virus lacking a functional pUL33, and the
resulting mutant B-like capsids were purified on two
sequential sucrose gradients as described previously. The
second gradient was fractionated, and the proteins
present in the fractions separated on two denaturing
8% polyacrylamide gels, transferred to nitrocellulose
membrane, and immunoblotted with antisera directed
against VP5 or pUL28. Immunoreactivity to the pUL28
protein was detected only in fractions containing capsids
(Fig. 5).
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The association of the UL33 protein in A, B, and C
capsids purified from HSV-1(F)-infected cells is consistent
Fig. 4. Digitally scanned images of fractionated sucrose gradients of nuclear lysates from Vero cells infected with mutant viruses lacking a functional UL6,
UL15, or UL28 gene. Capsids were purified through two sequential continuous sucrose gradients, and the second gradient fractionated from the top (fraction
one). Proteins in each fraction were denatured, electrophoretically separated on an 8% (top panels) or a 15% (bottom panels) polyacrylamide gel, and probed
with antisera directed against VP5 or pUL33. Bound antibody was visualized by the addition of alkaline-phosphatase-conjugated goat anti-rabbit
immunoglobulin followed by the addition of chromogenic substrate as described in Materials and methods.
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for DNA cleavage and packaging (Alkobaisi et al., 1991),
and that the UL33 protein localizes in the nuclear replication
compartments of infected cells (Reynolds et al., 2000) where
at least some of the DNA cleavage and packaging events
likely occur (Lamberti and Weller, 1998; Taus et al., 1998;
Ward et al., 1996). In addition, pUL33 forms a complex with
pUL15 and pUL28, two other capsid-associated proteins
required for cleavage and packaging (Beard et al., 2002).
This work describes the capsid association of pUL33 to besimilar to that of pUL15 and pUL28 (Salmon and Baines,
1998; Taus and Baines, 1998; Yu and Weller, 1998), consis-
tent with the hypothesis that pUL33 interacts with, or forms a
third component of, the terminase enzyme.
Because A and B capsids migrate closely together on a
20–50% sucrose gradient, it is often difficult to separate
them on a single sucrose gradient. In addition, relatively few
A capsids are produced in HSV-1(F)-infected cells, making
purification difficult in routine analyses. To overcome these
difficulties, A capsids from multiple gradients were pooled
Fig. 5. Immunoblot of purified capsids from UL33() virus. Capsids lacking pUL33 were purified through two sequential sucrose gradients and the second
gradient fractionated from the top (fraction one). The protein in each fraction was separated on an 8% denaturing polyacrylamide gel, transferred to
nitrocellulose membrane, and probed with antisera directed against VP5 (top panel) or pUL28 (bottom panel). Bound antibody was visualized by the addition of
alkaline-phosphatase-conjugated goat anti-rabbit immunoglobulin followed by the addition of chromogenic substrate as described in Materials and methods.
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4  108 cells) and purified through two successive sucrose
gradients. The absence of the scaffold protein VP22a from
the electrophoretic profile of the A capsids (Fig. 2B)
confirmed that this sample was not extensively contaminat-
ed with B capsids. A capsids are believed to represent
aborted packaging events during which DNA has begun to
be inserted into capsids, but for some reason is not retained
(Sherman and Bachenheimer, 1987). The observation that
pUL33 can be detected in A capsids suggests that the protein
remains attached to the capsid after DNA translocation has
been initiated.
It has been reported recently that there is significantly
more pUL15 in A than B capsids, but similar amounts of
pUL28 in both capsid types (Beard et al., 2004). In six out of
seven separate experiments comparing the amount of pUL33
in A and B capsids, there was comparatively more pUL33
detected in A than B capsids, a situation similar to that of
pUL15.
The resistance of the UL33 protein in B capsids to
guanidine–HCl extraction is similar to that of the scaffold
protein VP22a and other cleavage and packaging proteins
UL15 and UL28 (Salmon and Baines, 1998; Taus and
Baines, 1998; Yu and Weller, 1998), suggesting that they
are all associated with the capsid less avidly than the major
capsomere protein (VP5) and triplex proteins VP19c and
VP23.
The UL33 protein was found to associate with capsids
lacking the UL6, UL15, or UL28 proteins. This was not
unexpected because previously reported immunofluores-
cence data showed that the distribution of pUL33 in infected
cells was not altered by the absence of pUL15, pUL28, or
pUL6 (Reynolds et al., 2000), and the lack of any one of
these three proteins does not preclude the interaction of the
remaining two in vitro (Beard et al., 2002). It is therefore
apparent that the association of pUL33 with B-like capsids is
not dependent on pUL15, pUL28, or the putative portal
protein UL6. The converse is also true: the UL6, UL15, and
UL28 proteins all associate with capsids lacking pUL33
[(Patel et al., 1996; Salmon et al., 1999), this paper].
Although the association with intermediate capsids and
other putative terminase components provide indirect sup-port for the hypothesis that pUL33 plays a role as part of the
terminase holoenzyme, more direct proof will require fur-
ther studies, including documentation of terminase-like
activities using purified UL33 protein.Materials and methods
Viruses, cells, and antibodies
All cell lines were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% (v/v) newborn calf
serum, penicillin, and streptomycin. The wild-type HSV-
1(F) strain has been previously described (Ejercito and
Roizman, 1968) and was propagated and titrated on Vero
cell monolayers. The mutant viruses lacking UL6 (Patel and
Maclean, 1995), UL15 (Baines et al., 1997), UL18 (Desai et
al., 1993), UL28 (Tengelsen et al., 1993), and UL33 (Cun-
ningham and Davison, 1993) were propagated as described,
except for the UL33 mutant that was grown on D4 cells
(Salmon et al., 1999). The UL33- and UL28-specific rabbit
polyclonal antibodies have been previously described
(Beard et al., 2002; Reynolds et al., 2000); the VP5 antibody
(NC1-1) was a generous gift of Drs. R. Eisenburg and G.
Cohen (Cohen et al., 1980).
Capsid preparation and immunoblotting
Capsids were purified as described previously with some
modifications (Perdue et al., 1974). Unless otherwise stated
ten 175 cm2 flasks of Vero cells were infected at an MOI of
5 and incubated for 16 h at 37 jC. Nuclear lysates were
prepared by disruption in 1% triton-X and ultrasonification
for 40 s at moderate power. After clarification in a Sorvall
Legend RT centrifuge, Heraeus rotor #3334, 15 min at 8000
RPM (7227  G) at 4 jC, capsids in the supernatant were
pelleted through a 6 ml 35% (w/v) sucrose cushion in a
SW28.1 rotor for 1.5 h at 20000 RPM. The resultant pellet
was sonicated briefly, loaded on a 20–50% (w/v) continuous
sucrose gradient, and centrifuged for 1 h at 23000 rpm in a
SW41 rotor. Separate light scattering bands were collected
with Pasteur pipettes and capsids were pelleted at 30000
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the capsid-containing bands were then purified further on a
second identical sucrose gradient, the bands collected, cap-
sids pelleted, resuspended in 50 Al water (DNase-, RNase-,
and protease-free, [Acros]), and stored at 4 jC. Examination
of the material by electron microscopy showed minimal
background material (not shown). Where mentioned, frac-
tions of the sucrose gradients were collected using a fraction-
ing device (Haake Buchler) beginning at the top of the
gradient. Immunoblotting was carried out essentially as
previously described (Baines and Roizman, 1993). Unlike
previous studies (Reynolds et al., 2000), the antibody was
not extensively preadsorbed against cells infected with the
UL33 deletion virus. This improved sensitivity and did not
increase the number of nonspecific bands visualized in
immunoblots of capsid-associated proteins (not shown).
Bound antibody was detected using either horseradish per-
oxidase-conjugated goat anti-rabbit immunoglobulin fol-
lowed by the ECL+ development reagent (Amersham
Pharmacia Biotech) according to the manufacturer’s instruc-
tions and visualized using a Molecular Dynamics Storm
Imager and associated Imagequant software, or with alkaline
phosphatase-conjugated goat anti-rabbit immunoglobulin
followed by the chromogenic substrates NBT and BCIP
(Bio-Rad).
Guanidine–HCl treatment
B capsids were treated with varying concentrations of
guanidine–HCl as described previously (Newcomb and
Brown, 1991). A 4 M concentration of guanidine–HCl in
TNE was slowly added with extensive mixing to purified B
capsids such that the final concentrations were 0, 0.1, 0.25,
0.5, or 1 M GuHCl in a total volume of 1 ml. The samples
were then incubated on ice for 45 min with intermittent
agitation followed by centrifugation through a 25% (w/v)
sucrose cushion for 1 h in a SW50.1 rotor at 23 000 rpm.
The pellet was resuspended and equal amounts analyzed on
an 8% and a 15% denaturing polyacrylamide gel. The
amount of pUL33 present was detected using horseradish
peroxidase-conjugated goat anti-rabbit immunoglobulin fol-
lowed by the ECL+ development reagent (Amersham
Pharmacia Biotech) according to the manufacturer’s instruc-
tions, visualized using a Molecular Dynamics Storm Imager
and quantified using the associated Imagequant software.
The major capsid bands were visualized on the 8% gel
using Coomassie Brilliant Blue and quantified using a
flatbed digital scanner and Scion Image densitometry for
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